Concepedia

Andrew J. Tebben

AJ

Statistics

Publications

63

Citations

3.2K

H-Index

30

Active since

1992

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

United States Military Academy

Bristol-Myers Squibb (Sweden)

Andrew J. Tebben is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1992–2021

63

Publications

63

Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists

Yi Zheng, Ling Qin, Natalia V. Ortiz Zacarı́as et al. · Nature · 2016 · 296 citations · Full text

, , +14

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

Nigel J. Liverton, John W. Butcher, Christopher F. Claiborne et al. · Journal of Medicinal Chemistry · 1999 · 196 citations · Full text

, , +17

Macrocycle Conformational Sampling with MacroModel

K. Shawn Watts, Pranav Dalal, Andrew J. Tebben et al. · Journal of Chemical Information and Modeling · 2014 · 191 citations

, , +14

Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation

Neroshan Thevakumaran, Hugo Lavoie, David Critton et al. · Nature Structural & Molecular Biology · 2014 · 163 citations

, , +16

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α

Percy H. Carter, Peggy Scherle, Jodi A. Muckelbauer et al. · Proceedings of the National Academy of Sciences · 2001 · 140 citations · Full text

, , +16

1–5 of 63